ER

Eris Lifesciences LtdNSE ERIS Stock Report

Last reporting period 31 Mar, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

0.984

Micro

Exchange

XNSE - National Stock Exchange Of India

View Section: Eyestock Rating

Eris Fair Value

ER

The fair market value of ERIS.NS stock is 734.65 INR. Relative to the market price of 1369.45 INR Eris is overvalued by 46.4%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Greatly overvalued 46.4%
734.65 INR
ERIS.NS Fair Value
1 369.45 INR
Market price of ERIS.NS

Eris Valuation

Current ERIS.NS share ticker price is 1369.45 INR.

The fair value level of 734.65 INR can be considered as an effective entry point for long-term investors to start investing in ERIS.NS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 46% higher its fair value

Min value

Current price is 55% higher its minimum value

Max value

Current price is 37% higher its maximum value

13.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

ERIS.NS stock is greatly overvalued

It means the current price may concern as a High Risk Entry Point

Eris Lifesciences Ltd Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

30.1

2

Median P/E over 5 years

25.69

3

Minimum P/E over 5 years

21.7

4

Earning per share (last 12 months)

28.6 INR

Maximum value

1

x

4

=

860.87 INR

Fair value

2

x

4

=

734.65 INR

Minimum value

3

x

4

=

620.75 INR

Eris Lifesciences Ltd price metrics

25.48

Annual return (geometric mean)

31.69

Risk (standard deviation) of returns

β

-0.17

Beta (volatility compared to market)

It means that ERIS.NS stock and the market have an inverse correlation

Discover Undervalued Companies


View Section: Profitability